86 related articles for article (PubMed ID: 35170359)
1. Variant Hepatocellular Carcinoma Subtypes According to the 2019 WHO Classification: An Imaging-Focused Review.
Loy LM; Low HM; Choi JY; Rhee H; Wong CF; Tan CH
AJR Am J Roentgenol; 2022 Aug; 219(2):212-223. PubMed ID: 35170359
[TBL] [Abstract][Full Text] [Related]
2. Biphenotypic (hepatobiliary) primary liver carcinomas: the work in progress.
Brunt EM; Paradis V; Sempoux C; Theise ND
Hepat Oncol; 2015 Jul; 2(3):255-273. PubMed ID: 30191007
[TBL] [Abstract][Full Text] [Related]
3. MRI features of histologic subtypes of hepatocellular carcinoma: correlation with histologic, genetic, and molecular biologic classification.
Yoon JK; Choi JY; Rhee H; Park YN
Eur Radiol; 2022 Aug; 32(8):5119-5133. PubMed ID: 35258675
[TBL] [Abstract][Full Text] [Related]
4. MRI features associated with HCC histologic subtypes: a western American and European bicenter study.
Mulé S; Serhal A; Pregliasco AG; Nguyen J; Vendrami CL; Reizine E; Yang GY; Calderaro J; Amaddeo G; Luciani A; Miller FH
Eur Radiol; 2023 Feb; 33(2):1342-1352. PubMed ID: 35999375
[TBL] [Abstract][Full Text] [Related]
5. Morphomolecular Classification Update on Hepatocellular Adenoma, Hepatocellular Carcinoma, and Intrahepatic Cholangiocarcinoma.
Katabathina VS; Khanna L; Surabhi VR; Minervini M; Shanbhogue K; Dasyam AK; Prasad SR
Radiographics; 2022; 42(5):1338-1357. PubMed ID: 35776676
[TBL] [Abstract][Full Text] [Related]
6. Prognosis Prediction of Hepatocellular Carcinoma Based on Magnetic Resonance Imaging Features.
Low HM; Lee JM; Tan CH
Korean J Radiol; 2023 Jul; 24(7):660-667. PubMed ID: 37404108
[No Abstract] [Full Text] [Related]
7. Gd-EOB MRI for HCC subtype differentiation in a western population according to the 5
Auer TA; Halskov S; Fehrenbach U; Nevermann NF; Pelzer U; Mohr R; Hamm B; Schöning W; Horst D; Ihlow J; Geisel D
Eur Radiol; 2023 Oct; 33(10):6902-6915. PubMed ID: 37115216
[TBL] [Abstract][Full Text] [Related]
8. CT Radiomics to Predict Macrotrabecular-Massive Subtype and Immune Status in Hepatocellular Carcinoma.
Feng Z; Li H; Liu Q; Duan J; Zhou W; Yu X; Chen Q; Liu Z; Wang W; Rong P
Radiology; 2023 Apr; 307(1):e221291. PubMed ID: 36511807
[TBL] [Abstract][Full Text] [Related]
9. Hepatobiliary-phase gadolinium ethoxybenzyl-diethylenetriaminepentaacetic acid MRI for pretreatment prediction of efficacy-to-standard-therapies based on Barcelona Clinic Liver Cancer algorithm: an up-to-date review.
Minamiguchi K; Irizato M; Uchiyama T; Taiji R; Nishiofuku H; Marugami N; Tanaka T
Eur Radiol; 2023 Dec; 33(12):8764-8775. PubMed ID: 37470828
[TBL] [Abstract][Full Text] [Related]
10. Comparison of computed tomography and magnetic resonance imaging findings and histopathological features of macrotrabecular-massive hepatocellular carcinoma.
Gong Q; Zhang Y; Wu T; Du Z; Zhang Y
Quant Imaging Med Surg; 2023 Jul; 13(7):4633-4640. PubMed ID: 37456331
[TBL] [Abstract][Full Text] [Related]
11. Three-dimensional multifrequency magnetic resonance elastography improves preoperative assessment of proliferative hepatocellular carcinoma.
Liu G; Ma D; Wang H; Zhou J; Shen Z; Yang Y; Chen Y; Sack I; Guo J; Li R; Yan F
Insights Imaging; 2023 May; 14(1):89. PubMed ID: 37198348
[TBL] [Abstract][Full Text] [Related]
12. A radiomics nomogram for predicting cytokeratin 19-positive hepatocellular carcinoma: a two-center study.
Zhang L; Zhou H; Zhang X; Ding Z; Xu J
Front Oncol; 2023; 13():1174069. PubMed ID: 37182122
[TBL] [Abstract][Full Text] [Related]
13. Preoperative prediction of macrotrabecular-massive hepatocellular carcinoma through dynamic contrast-enhanced magnetic resonance imaging-based radiomics.
Zhang Y; He D; Liu J; Wei YG; Shi LL
World J Gastroenterol; 2023 Apr; 29(13):2001-2014. PubMed ID: 37155523
[TBL] [Abstract][Full Text] [Related]
14. Comparison of imaging findings of macrotrabecular-massive hepatocellular carcinoma using CT and gadoxetic acid-enhanced MRI.
Cha H; Choi JY; Park YN; Han K; Jang M; Kim MJ; Park MS; Rhee H
Eur Radiol; 2023 Feb; 33(2):1364-1377. PubMed ID: 35999373
[TBL] [Abstract][Full Text] [Related]
15. Vessels that encapsulate tumour clusters vascular pattern in hepatocellular carcinoma.
Liu K; Dennis C; Prince DS; Marsh-Wakefield F; Santhakumar C; Gamble JR; Strasser SI; McCaughan GW
JHEP Rep; 2023 Aug; 5(8):100792. PubMed ID: 37456680
[TBL] [Abstract][Full Text] [Related]
16. Preoperative prediction model for macrotrabecular-massive hepatocellular carcinoma based on contrast-enhanced CT and clinical characteristics: a retrospective study.
He C; Zhang W; Zhao Y; Li J; Wang Y; Yao W; Wang N; Ding W; Wei X; Yang R; Jiang X
Front Oncol; 2023; 13():1124069. PubMed ID: 37197418
[TBL] [Abstract][Full Text] [Related]
17. A model incorporating histopathology and preoperative gadoxetic acid-enhanced MRI to predict early recurrence of hepatocellular carcinoma without microvascular invasion after curative hepatectomy.
Qu Q; Lu M; Xu L; Zhang J; Liu M; Jiang J; Zhao X; Zhang X; Zhang T
Br J Radiol; 2023 Mar; 96(1144):20220739. PubMed ID: 36877238
[TBL] [Abstract][Full Text] [Related]
18.
Hu S; Kang Y; Xie Y; Yang T; Yang Y; Jiao J; Zou Q; Zhang H; Zhang Y
Abdom Radiol (NY); 2023 Feb; 48(2):532-542. PubMed ID: 36370179
[TBL] [Abstract][Full Text] [Related]
19. Dynamic CT and Gadoxetic Acid-enhanced MRI Characteristics of P53-mutated Hepatocellular Carcinoma.
Kitao A; Matsui O; Zhang Y; Ogi T; Nakada S; Sato Y; Harada K; Yoneda N; Kozaka K; Inoue D; Yoshida K; Koda W; Yamashita T; Yamashita T; Kaneko S; Kobayashi S; Gabata T
Radiology; 2023 Feb; 306(2):e220531. PubMed ID: 36219111
[TBL] [Abstract][Full Text] [Related]
20. The significance of the predominant component in combined hepatocellular-cholangiocarcinoma: MRI manifestation and prognostic value.
Sheng R; Yang C; Zhang Y; Wang H; Zheng B; Han J; Sun W; Zeng M
Radiol Med; 2023 Sep; 128(9):1047-1060. PubMed ID: 37474663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
